Close
ACHEMA MIDDLE EAST 2026

World-Class Biopharma Production Offered By APAC Bioclusters

Worldwide pharmaceutical companies look to advance the development of molecules from the laboratory to the clinic and then market them as soon as possible....

M&A In Biopharmaceuticals Raise To New Levels In 2024 Q1

It has indeed been a roller coaster ride for the biopharmaceutical sector ever since the pandemic-led surge in 2020. Since 2023, the resurgence when...

Global Biopharma Market – Prominent Growth In Years To Come

The worldwide biopharmaceutical market is all set to have prominent growth, with the value anticipated to reach $566 billion by 2032, which is up...

Biopharma Manufacturing & Generative AI – A Lot To Look Into

As per a new Axendia Market Research Report: The State of Generative AI in Life Sciences: The Good, the Bad, and the Ugly, among...

$60bn Valuation For Global Biopharma CMO-CRO Market By 2033

It is well to be noted that the worldwide biopharmaceutical CMO as well as CRO market is anticipated to witness quite significant growth in...

Australia Biomedical Space Drives World Innovation, Research

It is worth noting that the new Australian Institute for Infectious Diseases- AIID has been established so as to bring together some of the...

Titan Krios G4 – A Biomed Research Advancement In Australia

In May 2024, the Ramaciotti Centre for Cryo-Electron Microscopy went on to launch the Titan Krios G4 microscope, a state-of-the-art instrument that happens to...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...